15:59 Jul 26
Cipla Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Cipla Ltd.
84/100 High Financial Strength
Quality40/100 Mid Valuation
Valuation67/100 Technically Moderately Bullish
TechnicalSWOT
Strength
13
Weakness
1
Opportunity
3
Threat
1
1.27L
Market Cap (Cr)
29.55
PE Ratio
4.76
Price to Book Ratio
68.23
RSI
15.99 %
Net Profit Margin
Rating Based on 10 Analysts
Buy
80%
Hold
20%
Sell
0%
Buy
Analyst Price Target
The average price target is 1601.4 with a high estimate of 1776 and low estimate of 1365
Current 1575.00
Disclaimer:The analysis information is for reference only and does not constitute an investment recommendation
SWOT
Download Our App On:
